Perseon Corporation (Nasdaq:PRSN) (Perseon of the Company), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced plans to release its financial results for the first quarter ended March 31, 2015 before the market opens on Thursday, May 14, 2015. The Company will host a corresponding conference call with a live webcast later that day at 2:00 p.m. Eastern Time/12:00 p.m. Mountain Time.

Individuals interested in listening to the conference call may do so by visiting the Investor Relations section of the Company's website at www.perseonmedical.com or by dialing 800.860.2442 from the United States, or 412.858.4600 from outside the United States, and referencing "Perseon Corporation." We request that you RSVP to the conference call by emailing tross@finprofiles.com before 4:00 p.m. Eastern time on Tuesday, May 12, 2015.

A telephone replay will be available through May 21, 2015, by dialing 877.344.7529 from the United States, or 412.317.0088 from outside the United States, and entering conference ID 10064204. A webcast replay will be available for 90 days.

About Perseon

Perseon Corporation, formerly BSD Medical Corporation, invests its resources in fighting humanity's worst disease: cancer. Perseon's people are dedicated to finding innovative technologies and means to deliver microwave ablation solutions to healthcare providers and patients around the world. MicroThermX® treats soft tissue tumors with precision-focused microwave energy, expanding the options and broadening the opportunities for cancer treatment.

Forward-Looking Statements

Statements contained in this press release that are not historical facts, including statements relating to our intent to divest our hyperthermia business in Spring 2015, focus on microwave ablation to create stockholder value, comply with Nasdaq continued listing requirements, generate capital from a transaction related to our building and pursue other strategic plans are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties, including the risk that for a variety of reasons we may not be able to execute on our strategic plans, and other risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date, except as required by law.

CONTACT: Tricia Ross
         Financial Profiles
         310-622-8226
         tross@finprofiles.com